NALOXONE HYDROCHLORIDE
- Product NDC
- 45802-811
- 11-digit product format
- 458020811
- Labeler code
- 45802
- Product ID
- 45802-811_29fa6170-7b01-48a2-9e55-e213325e2d25
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- naloxone hydrochloride
- Dosage form
- SPRAY
- Route
- NASAL
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Application
- ANDA211951
- Marketing category
- ANDA
- Marketing start
- 2022-06-21
- Marketing end
- 0000-00-00
- Substance
- NALOXONE HYDROCHLORIDE
- Active strength
- 4 mg/.1mL
- Pharmacologic classes
- Opioid Antagonist [EPC], Opioid Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 45802-811 | D | Discontinued by firm | 2026-08-11 | ||
| excluded package | package | 45802-811 | 45802-811-84 | D | Discontinued by firm | 2026-08-11 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | 45802-811 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | ||
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 45802-811 | 45802-811-84 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A211951-001 | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 8072bd15b7f6… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | AB | 2022-06-21 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | AB | 2022-06-21 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | AB | 2022-06-21 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | AB | 2022-06-21 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | AB | 2022-06-21 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | AB | 2022-06-21 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | AB | 2022-06-21 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | AB | 2022-06-21 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A211951-001 | NALOXONE HYDROCHLORIDE | 4MG/SPRAY | SPRAY, METERED / NASAL | 2022-06-21 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A211951-001 | AB | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A211951-001 | AB | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A211951-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A211951-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A211951-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A211951-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A211951-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A211951-001 | AB | 1 | cb3db0bc1861… |
DailyMed Product Concepts#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 45802-811-00 | EA - Each | 45802-811 | 2584cf2b-1ccf-4b35-8860-0a02bab3901a | 1 | 2022-07-06 |
| 45802-811-84 | EA - Each | 45802-811 | bd196d34-6b1d-493f-85b8-ffb1be112ee7 | 1 | 2022-07-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | BluePoint Laboratories | 327004b0-560a-84d0-e063-6294a90aa743 | 2026-04-02 | Warnings | 211951 ANDA211951 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | b5d40220-f194-4835-b70c-f304ecb222d5 | 2026-01-06 | Warnings | 211951 ANDA211951 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Strategic Sourcing Services LLC | 577fbd57-7054-4536-86c1-d43bc99cc7b1 | 2025-11-19 | Warnings | 211951 ANDA211951 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | AMERISOURCE BERGEN | cce38c13-0d2f-49bb-94fa-6f2bbb4d5984 | 2025-08-31 | Warnings | 211951 ANDA211951 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Bryant Ranch Prepack | ed549649-dcbd-41f7-a774-876906751c5a | 2024-10-03 | Warnings | 211951 ANDA211951 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 1be2e38b-55ca-abea-e063-6394a90ac548 | 2024-06-27 | Warnings | 211951 ANDA211951 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 19b0603b-241f-f439-e063-6294a90ae85f | 2024-05-30 | Warnings | 211951 ANDA211951 |
| NALOXONE HCl | NALOXONE HCL | HF Acquisition Co LLC, DBA HealthFirst | f8fcda15-8ba6-e66a-e053-6294a90a385c | 2024-01-28 | Warnings, Adverse reactions | 211951 ANDA211951 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | A-S Medication Solutions | 46f27d04-d4d2-4ef1-9cc5-4d58f4056f06 | 2023-12-27 | Warnings | 211951 ANDA211951 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | A-S Medication Solutions | 0b3b5214-6f91-4bba-82d6-d57b16845df5 | 2023-10-01 | Warnings, Adverse reactions | 211951 ANDA211951 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Proficient Rx LP | 8d529b4c-85fd-4e50-9443-9080825307bf | 2022-10-01 | Warnings, Adverse reactions | 211951 ANDA211951 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1725059 | naloxone HCl 4 MG in 0.1 ML Nasal Spray | PSN | f8fcda15-8ba6-e66a-e053-6294a90a385c | 2 |
| 1725059 | naloxone hydrochloride 40 MG/ML Nasal Spray | SCD | f8fcda15-8ba6-e66a-e053-6294a90a385c | 2 |
| 1725059 | naloxone HCl 4 MG per 0.1 ML Nasal Spray | SY | f8fcda15-8ba6-e66a-e053-6294a90a385c | 2 |
| 1725059 | naloxone HCl 4 MG in 0.1 ML Nasal Spray | PSN | 0b3b5214-6f91-4bba-82d6-d57b16845df5 | 1 |
| 1725059 | naloxone HCl 4 MG in 0.1 ML Nasal Spray | PSN | 1e04b8aa-2363-34cd-e063-6394a90aa3f5 | 1 |
| 1725059 | naloxone HCl 4 MG in 0.1 ML Nasal Spray | PSN | 8d529b4c-85fd-4e50-9443-9080825307bf | 1 |
| 1725059 | naloxone hydrochloride 40 MG/ML Nasal Spray | SCD | 0b3b5214-6f91-4bba-82d6-d57b16845df5 | 1 |
| 1725059 | naloxone hydrochloride 40 MG/ML Nasal Spray | SCD | 1e04b8aa-2363-34cd-e063-6394a90aa3f5 | 1 |
| 1725059 | naloxone hydrochloride 40 MG/ML Nasal Spray | SCD | 8d529b4c-85fd-4e50-9443-9080825307bf | 1 |
| 1725059 | naloxone HCl 4 MG per 0.1 ML Nasal Spray | SY | 0b3b5214-6f91-4bba-82d6-d57b16845df5 | 1 |
| 1725059 | naloxone HCl 4 MG per 0.1 ML Nasal Spray | SY | 1e04b8aa-2363-34cd-e063-6394a90aa3f5 | 1 |
| 1725059 | naloxone HCl 4 MG per 0.1 ML Nasal Spray | SY | 8d529b4c-85fd-4e50-9443-9080825307bf | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 45802-811-84 | 45802081184 | 2 VIAL, SINGLE-DOSE in 1 CARTON (45802-811-84) > .1 mL in 1 VIAL, SINGLE-DOSE (45802-811-00) | 2022-06-21 | 0000-00-00 | No | No | Current |